Revumenib CAS No.2169919-21-3
Revumenib CAS No.2169919-21-3
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-R-2425 | 10mg | 340.00 | + Add to cart |
|
R-R-2425 | 25mg | 680.00 | + Add to cart |
|
|
Product description
Revumenib (SNDX-5613)/CAS No.2169919-21-3 is a potent and specific Menin-MLL inhibitor with a binding Ki of 0.149 nM and a cell based IC50 of 10-20 nM. Revumenib can be used for the research of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
Appearance | N/A |
---|---|
Molecular Weight | 630.82 |
Purity | >90% |
CAS | 2169919-21-3 |
Formula | C32H47FN6O4S |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product